Noronex Ltd. AI Stock Analysis
Want to see AU:NRX full AI Analyst Report?
Noronex Ltd. (NRX) AI Stock Analysis
Noronex Ltd.
(ASX:NRX)
The overall score is constrained by a critical disconnect between reported profits and actual cash generation. While the debt-free balance sheet and a recent turn to net profitability are positive, the deeply negative operating cash flow is a major red flag for sustainability. Technical trends are weak, with the stock trading below key moving averages, and the low P/E ratio is undermined by the company's tiny, unproven revenue base. The primary risk is the company's inability to convert accounting profit into cash, which overshadows its recent income statement improvements.
Noronex Ltd. (NRX) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 7.40M
- Dividend Yield
- ―
- Average Volume (3M)
- 741.60K
- Price to Earnings (P/E)
- 5.9
- Beta (1Y)
- 0.96
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Australia
- Employees
- 0
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Copper
Noronex Ltd. Business Overview & Revenue Model
Company Description
Noronex Limited is primarily involved in the exploration of minerals. Their efforts specifically target the discovery of base metals, precious metals, and copper deposits. A key focus is the Witvlei project, situated in Namibia's Kalahari Copper Belt...
Noronex Ltd. Financial Statement Overview
Summary
Financial performance is mixed. The income statement shows a dramatic turnaround to profitability (Score: 65) and the balance sheet is debt-free with improving equity (Score: 70), but the cash flow statement is critically weak with deeply negative operating cash flow despite reported profits (Score: 25). The severe cash conversion problem significantly drags down the overall financial health score.
Income Statement
65PositiveBalance Sheet
70PositiveCash Flow
25Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.31M | 2.31M | 368.16K | 40.68K | 0 | 0 |
| Gross Profit | 2.37M | 2.86M | 368.16K | 40.68K | 0 | 0 |
| EBITDA | 598.28K | 2.81M | -1.08M | 10.60K | 18.51K | 8,405 |
| Net Income | 1.15M | 1.15M | -3.13M | -2.51M | -3.35M | -5.55M |
Balance Sheet | ||||||
| Total Assets | 3.19M | 3.19M | 2.20M | 3.81M | 3.32M | 5.05M |
| Cash, Cash Equivalents and Short-Term Investments | 1.41M | 1.41M | 1.01M | 913.58K | 393.75K | 2.11M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 186.43K | 186.43K | 1.22M | 754.42K | 424.52K | 468.48K |
| Stockholders Equity | 3.23M | 3.23M | 951.15K | 3.02M | 2.85M | 4.36M |
Cash Flow | ||||||
| Free Cash Flow | -5.89M | -5.89M | -3.68M | -2.36M | -3.12M | -5.36M |
| Operating Cash Flow | -5.89M | -5.89M | -3.68M | -2.36M | -3.12M | -5.28M |
| Investing Cash Flow | 1.44M | 1.44M | -42.61K | 412.06K | 0 | -80.00K |
| Financing Cash Flow | 5.05M | 5.05M | 3.78M | 2.47M | 1.42M | 4.46M |
Noronex Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NRX, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 48.15 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:NRX.
Noronex Ltd. Peers Comparison
Overall Rating
AU:NRX50Neutral
AU:NFM45Neutral
AU:TNC42Neutral
AU:CYM41Neutral
AU:CVV40Underperform
AU:HCH40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 50Neutral | AUD 7.40M | 5.88 | 49.80% | ― | ― | ― | |
| 45Neutral | AUD 6.95M | -3.93 | -14.04% | ― | ― | 37.50% | |
| 42Neutral | AUD 41.21M | -18.18 | -1.15% | ― | -100.00% | 99.56% | |
| 41Neutral | AUD 195.40M | -10.41 | -9.20% | ― | ― | 81.09% | |
| 40Underperform | AUD 92.20M | -4.54 | 634.53% | ― | ― | -163.77% | |
| 40Underperform | AUD 240.44M | -20.94 | -4.15% | ― | ― | 22.68% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:NRX | Noronex Ltd. | 0.01 | -0.00 | -33.33% | |
| AU:HCH | Hot Chili Limited | 1.19 | 0.41 | 51.92% | |
| AU:NFM | Castillo Copper Ltd. | 0.01 | -0.01 | -58.33% | |
| AU:CYM | Cyprium Metals Limited | 0.30 | -0.01 | -4.39% | |
| AU:CVV | Caravel Minerals Limited | 0.17 | -0.07 | -31.25% | |
| AU:TNC | True North Copper Limited | 0.20 | -0.19 | -48.72% |
Noronex Ltd. Corporate Events
Noronex Commences Copper-Silver Drilling in Namibia and Botswana
Noronex has commenced an approximately 4,600-metre, 15-hole reverse-circulation drilling campaign across its Namibia and Botswana projects. Targets include new areas at Rosy Copper, Epikuro River and Helena East in Namibia, plus follow-up drilling at...
Noronex Secures Alaskan Tin Project and Advances Critical Metals Strategy
Noronex has completed the acquisition of 100% of the high-grade Sleitat Tin Project in Alaska, one of the few large-scale tin projects in the United States, and has undertaken maiden field mapping and high-resolution geophysical surveys to define the...
Noronex survey reveals major extensions at Alaska Sleitat tin system
Noronex has reported encouraging results from a high-resolution airborne magnetic, radiometric and VLF-EM survey over its Sleitat Tin-Tungsten-Silver Project in Alaska. The data confirm that tin-bearing greisen rock extends for more than one kilometr...
Noronex Completes Maiden Sleitat Exploration and Strengthens Alaskan Team
Noronex has completed its maiden field exploration and high-resolution geophysical programs at the 100%-owned Sleitat tin-tungsten-silver project in Alaska, marking the first systematic modern survey of the broader mineralised system. The work, which...
Noronex Files Appendix 4G, Confirms ASX Governance Compliance
Noronex Limited has lodged its Appendix 4G and confirmed that its corporate governance statement for the year ended 30 June 2026 is current as at 30 September 2026 and approved by the board. The company reports that it follows key ASX Corporate Gover...
Noronex Releases Comprehensive Annual Report for FY2026
Noronex Ltd. has released its annual report for the year ended 30 June 2026, comprising the directors’ report, audited consolidated financial statements, cash flow and equity statements, and other statutory disclosures. The document also includes an...
Noronex Updates Market on Director Equity Incentives
Noronex Limited is an Australia-listed company, with its securities traded on the ASX. The company operates under Australian corporate and securities regulations, and its directors’ holdings and changes in interests are disclosed in line with ASX lis...
Noronex Director David Prentice Granted Additional Equity Incentives
Noronex Limited has disclosed a change in director David Prentice’s interests following the issue of new equity incentives. Prentice received 2,000,000 unquoted options exercisable at $0.025 each to 7 September 2028 and 2,000,000 performance rights,...
Noronex Clears New Share Issue for On-Sale Under Corporations Act Exemption
Noronex Limited, an ASX-listed copper explorer with projects in the Kalahari Copper Belt and Ontario, is advancing its portfolio through significant historical drilling and strategic earn-in agreements with South32. The company also maintains exposur...
Noronex Seeks ASX Quotation for 4 Million New Ordinary Shares
Noronex Ltd., listed on the ASX under code NRX, focuses on maintaining an actively traded register of ordinary fully paid shares as its primary listed securities, in line with Australian market and regulatory standards for quoted equity. The company’...
Noronex Seeks ASX Quotation for 88.8 Million New Shares
Noronex Limited has applied for quotation on the ASX of 88,843,956 ordinary fully paid shares under the code NRX, with an issue date of 7 September 2026. The application formalises the move to have these securities trading on the exchange, potentiall...
Noronex Issues New Unquoted Performance Rights and Options
Noronex Ltd., listed on the ASX under code NRX, has disclosed changes to its capital structure via the issuance of new unquoted equity instruments. The move underscores the company’s continued reliance on performance-linked rights and options to alig...
Noronex Issues New Unquoted Performance Rights and Options
Noronex Limited has notified the market of a new issue of unquoted equity securities, expanding its pool of performance-based instruments. The company has created significant additional incentives that are designed to support executive and employee a...
Noronex Shareholders Back All Resolutions at General Meeting
Noronex Limited has reported that all resolutions put to shareholders at its 4 September general meeting were passed by poll. The approved items include ratification of previous share and option issues, new share issuances linked to settlement and fa...
Noronex Launches First Modern Exploration at Alaska’s Sleitat Tin Project
Noronex Ltd., an ASX-listed explorer focused on tin, tungsten and silver, is advancing its North American footprint through the Sleitat Tin Project in Alaska. Sleitat is recognised by the USGS as one of only two likely economic tin deposits in the U....
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 07, 2026
